Nav: Home

Simple, inexpensive risk score can shorten length of stay for MI patients

October 23, 2012

MINNEAPOLIS, MN--October 23, 2012--A simple-to-use risk score can identify low-risk patients following a severe heart attack (STEMI) and may provide an opportunity to employ early discharge strategies to reduce length of hospital stay and save hospital costs without compromising the safety of the patient, based on a study presented by the Minneapolis Heart Institute Foundation on Oct. 23 at the 2012 Transcatheter Cardiovascular Therapeutics (TCT) conference.

Recently, there has been an emphasis on lowering both hospital length of stay and hospital readmission in patients with severe heart attack, or ST-elevation myocardial infarction (STEMI), to decrease costs to the overall healthcare system. STEMI patients in the U.S. have lower length of stay in the hospital but increased rates of hospital readmissions compared with other countries.

The Zwolle PCI Risk Index Scoring System is validated to identify low-risk STEMI patients for early discharge. "This is a simple-to-calculate risk score, which takes into account age, three-vessel disease, Killip Class, anterior infarction, ischemic time and TIMI flow post," says the study's senior author Timothy D. Henry, MD, an interventional cardiologist at the Minneapolis Heart Institute® (MHI) at Abbott Northwestern Hospital and director of research with the Minneapolis Heart Institute Foundation. "These risk factors can be easily and quickly assessed by the healthcare professionals within a hospital."

For the study, Craig E. Strauss, MD, MPH, a cardiologist at MHI at Abbott Northwestern, and colleagues retrospectively applied the Zwolle Risk Score to all STEMI patients presenting to their large, regional STEMI system between January 2009 and December 2011.

Among the 967 cases, 44 percent were classified as high risk and 56 percent as low risk. High-risk patients were older, had more hypertension, diabetes and previous coronary artery disease, were more likely to have had previous revascularization and had lower left ventricular ejection fractions.

The low-risk patients had statistically significant lower mortality rates than the high-risk patients in the in-hospital setting (0 vs. 11.9 percent), at 30 days (0.2 vs. 12.9 percent) and at one year (3.9 vs. 16.4 percent). Likewise, the low-risk patients had fewer complication rates across the board: any complication (6.5 vs. 17.1 percent), heart failure (0.3 vs. 2.1 percent), cardiogenic shock (0.3 vs. 5.1 percent) or new dialysis (0 vs. 1.7 percent).

"Because there is increasing pressure to reduce rising hospital costs while also reducing readmissions, this study's findings are particularly important," says Dr. Henry. "We found that identifying low-risk patients in an easy, inexpensive manner can lead to safe discharge a full day in advance of the high-risk STEMI patients."

The discharge of one day in advance for these low-risk patients led to a savings of nearly $7,000 in total hospital costs.

"Prospective use of this risk score may provide an opportunity to safely employ early discharge strategies to reduce length of stay and total hospital costs without compromising patient safety," the study authors concluded.

"This study's findings have immediately manifested into a change in our clinical practice. As part of our overall quality improvement program, we are going to use the Zwolle Risk Score to identify low-risk patients, and these patients will avoid the cardiac critical care unit and will have a plan to be discharged in 48 hours," adds Dr. Henry. "This change in patient management is the result of the safety findings with this low-risk patient population in the study."
-end-
About the Minneapolis Heart Institute Foundation

The Minneapolis Heart Institute Foundation is dedicated to creating a world without heart disease through groundbreaking clinical research and innovative education programs. MHIF's mission is to promote and improve cardiovascular health, quality of life and longevity for all.
  • Scientific Innovation and Research - Publishing more than 120 peer-reviewed studies each year, MHIF is a recognized research leader in the broadest range of cardiovascular medicine. Each year, cardiologists and hospitals around the world adopt MHIF protocols to save lives and improve patient care.
  • Education and Outreach - Research shows that modifying specific health behaviors can significantly reduce the risk of developing heart disease. Through community programs, screenings and presentations, MHIF educates people of all walks of life about heart health. The goal of the Foundation's community outreach is to increase personal awareness of risk factors and provide the tools necessary to help people pursue heart- healthy lifestyles.
About the Minneapolis Heart Institute®

The Minneapolis Heart Institute® is recognized internationally as one of the world's leading providers of heart and vascular care. This state-of-the-art facility combines the finest in personalized patient care with sophisticated technology in a unique, family-oriented environment. The Institute's programs, a number of which are conducted in conjunction with Abbott Northwestern Hospital, address the full range of heart and vascular health needs: prevention, diagnosis, treatment and rehabilitation.

Contact:
Steve Goodyear
Minneapolis Heart Institute Foundation
612-863-1658
sgoodyear@mhif.org
http://mhif.org

Minneapolis Heart Institute Foundation

Related Research Articles:

More Research News and Research Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.